Oxcarbamezapine
Pain Management
Rehman Medical Institute - RMIPhase 2/3Active
B
58/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 81/ 100
Competitive context
13 Active assets in the Pain Management cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans) | Phase 4 | BB |
NEPENTHE Michał Borys | Phase 4 | BB |
METAMIZOLE Michał Borys | Phase 4 | BB |
(RS)-KETOPROFEN Michał Borys | Phase 4 | BB |
IBUPROFEN Universidad Europea de Madrid | Phase 4 | BB |
View all 18 →
Same molecule, other indications
Oxcarbamezapine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →